Ellen Nolte1, Chris Bain, Martin McKee. 1. European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK. ellen.nolte@lshtm.ac.uk
Abstract
OBJECTIVE: To assess the performance of health systems using diabetes as a tracer condition. RESEARCH DESIGN AND METHODS: We generated a measure of "case-fatality" among young people with diabetes using the mortality-to-incidence ratio (M/I ratio) for 29 industrialized countries using published data on diabetes incidence and mortality. Standardized incidence rates for ages 0-14 years were extracted from the World Health Organization DiaMond study for the period 1990-1994; data on death from diabetes for ages 0-39 years were obtained from the World Health Organization mortality database and converted into age-standardized death rates for the period 1994-1998, using the European standard population. RESULTS: The M/I ratio varied >10-fold. These relative differences appear similar to those observed in cohort studies of mortality among young people with type 1 diabetes in five countries. A sensitivity analysis showed that using plausible assumptions about potential overestimation of diabetes as a cause of death and underestimation of incidence rates in the U.S. yields an M/I ratio that would still be twice as high as in the U.K. or Canada. CONCLUSIONS: The M/I ratio for diabetes provides a means of differentiating countries on quality of care for people with diabetes. It is solely an indicator of potential problems, a basis for stimulating more detailed assessments of whether such problems exist, and what can be done to address them.
OBJECTIVE: To assess the performance of health systems using diabetes as a tracer condition. RESEARCH DESIGN AND METHODS: We generated a measure of "case-fatality" among young people with diabetes using the mortality-to-incidence ratio (M/I ratio) for 29 industrialized countries using published data on diabetes incidence and mortality. Standardized incidence rates for ages 0-14 years were extracted from the World Health Organization DiaMond study for the period 1990-1994; data on death from diabetes for ages 0-39 years were obtained from the World Health Organization mortality database and converted into age-standardized death rates for the period 1994-1998, using the European standard population. RESULTS: The M/I ratio varied >10-fold. These relative differences appear similar to those observed in cohort studies of mortality among young people with type 1 diabetes in five countries. A sensitivity analysis showed that using plausible assumptions about potential overestimation of diabetes as a cause of death and underestimation of incidence rates in the U.S. yields an M/I ratio that would still be twice as high as in the U.K. or Canada. CONCLUSIONS: The M/I ratio for diabetes provides a means of differentiating countries on quality of care for people with diabetes. It is solely an indicator of potential problems, a basis for stimulating more detailed assessments of whether such problems exist, and what can be done to address them.
Authors: Dimitrios Charalampopoulos; Julia M Hermann; Jannet Svensson; Torild Skrivarhaug; David M Maahs; Karin Akesson; Justin T Warner; Reinhard W Holl; Niels H Birkebæk; Ann K Drivvoll; Kellee M Miller; Ann-Marie Svensson; Terence Stephenson; Sabine E Hofer; Siri Fredheim; Siv J Kummernes; Nicole Foster; Lena Hanberger; Rakesh Amin; Birgit Rami-Merhar; Anders Johansen; Knut Dahl-Jørgensen; Mark Clements; Ragnar Hanas Journal: Diabetes Care Date: 2018-04-12 Impact factor: 19.112
Authors: Benjamin G Druss; Liping Zhao; Janet R Cummings; Ruth S Shim; George S Rust; Steven C Marcus Journal: Med Care Date: 2012-05 Impact factor: 2.983
Authors: Dionne S Kringos; Wienke G W Boerma; Allen Hutchinson; Jouke van der Zee; Peter P Groenewegen Journal: BMC Health Serv Res Date: 2010-03-13 Impact factor: 2.655
Authors: Christine M Everett; Carolyn T Thorpe; Mari Palta; Pascale Carayon; Valerie J Gilchrist; Maureen A Smith Journal: Med Care Res Rev Date: 2013-07-17 Impact factor: 3.929
Authors: Willemijn L A Schäfer; Wienke G W Boerma; Dionne S Kringos; Jan De Maeseneer; Stefan Gress; Stephanie Heinemann; Danica Rotar-Pavlic; Chiara Seghieri; Igor Svab; Michael J Van den Berg; Milena Vainieri; Gert P Westert; Sara Willems; Peter P Groenewegen Journal: BMC Fam Pract Date: 2011-10-20 Impact factor: 2.497